Andreas Reinisch

Immune cells mimic the morphology of endothelial progenitor colonies in vitro.

Humanized system to propagate cord blood-derived multipotent mesenchymal stromal cells for clinical application.

Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells.

Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum.

Humanized large-scale expanded endothelial colony-forming cells function in vitro and in vivo.

Platelet-derived growth factors for GMP-compliant propagation of mesenchymal stromal cells.

Replicative senescence-associated gene expression changes in mesenchymal stromal cells are similar under different culture conditions.

Pro-angiogenic induction of myeloid cells for therapeutic angiogenesis can induce mitogen-activated protein kinase p38-dependent foam cell formation.

Human dermis harbors distinct mesenchymal stromal cell subsets.

Increased Expression of Micro-RNA-23a Mediates Chemoresistance to Cytarabine in Acute Myeloid Leukemia.

A Dysregulated DNA Methylation Landscape Linked to Gene Expression in MLL-Rearranged AML.

Human extramedullary bone marrow in mice: a novel in vivo model of genetically controlled hematopoietic microenvironment.

Oxygen sensing mesenchymal progenitors promote neo-vasculogenesis in a humanized mouse model in vivo.

Identification of an effective early signaling signature during neo-vasculogenesis in vivo by ex vivo proteomic profiling.

Placental mesenchymal stromal cells derived from blood vessels or avascular tissues: what is the better choice to support endothelial cell function?

Epigenetic and in vivo comparison of diverse MSC sources reveals an endochondral signature for human hematopoietic niche formation.

Autologous cell sources in therapeutic vasculogenesis: In vitro and in vivo comparison of endothelial colony-forming cells from peripheral blood and endothelial cells isolated from adipose tissue.

Identification of the Human Skeletal Stem Cell.

High GPR56 surface expression correlates with a leukemic stem cell gene signature in CD34-positive AML.

TP53 mutated AML subclones exhibit engraftment in a humanized bone marrow ossicle mouse model.

Sensitive and broadly applicable residual disease detection in acute myeloid leukemia using flow cytometry-based leukemic cell enrichment followed by mutational profiling.

Micro-RNA-125a mediates the effects of hypomethylating agents in chronic myelomonocytic leukemia.

EZH2 inactivation in RAS-driven myeloid neoplasms hyperactivates RAS-signaling and increases MEK inhibitor sensitivity.

miR-23a mediates resistance to hypomethylating agents in myeloid neoplasms.

Targeted regulation of transcription in primary cells using CRISPRa and CRISPRi.

Fasting improves therapeutic response in hepatocellular carcinoma through p53-dependent metabolic synergism.

Comparison of acute myeloid leukemia and myelodysplastic syndromes with TP53 aberrations.

Targeting human CALR-mutated MPN progenitors with a neoepitope-directed monoclonal antibody.

The Cell Type-Specific 5hmC Landscape and Dynamics of Healthy Human Hematopoiesis and TET2-Mutant Preleukemia.

Dysregulated Lipid Synthesis by Oncogenic IDH1 Mutation Is a Targetable Synthetic Lethal Vulnerability.

Thrombopoietin-independent Megakaryocyte Differentiation of Hematopoietic Progenitor Cells from Patients with Myeloproliferative Neoplasms.

Human gene-engineered calreticulin mutant stem cells recapitulate MPN hallmarks and identify targetable vulnerabilities.